Ahmad A (2019) Breast cancer statistics: recent trends. Adv Exp Med Biol 1152:1–7

Article  CAS  PubMed  Google Scholar 

Barroso-Sousa R, Jain E, Cohen O, Kim D, Buendia-Buendia J, Winer E et al (2020) Prevalence and mutational determinants of high tumor mutation burden in breast cancer. Ann Oncol : Off J Eur Soc Med Oncol 31(3):387–394

Article  CAS  Google Scholar 

Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH et al (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575(7784):688–692

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 68(6):394–424

PubMed  Google Scholar 

Carpenco E, Ceauşu RA, Cimpean AM, Gaje PN, Șaptefraţi L, Fulga V et al (2019) Mast cells as an indicator and prognostic marker in molecular subtypes of breast cancer. In Vivo (Athens, Greece) 33(3):743–748

CAS  PubMed  Google Scholar 

Chopra N, Tovey H, Pearson A, Cutts R, Toms C, Proszek P et al (2020) Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer. Nat Commun 11(1):2662

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I et al (2019) FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575(7784):693–698

Article  ADS  CAS  PubMed  Google Scholar 

Engebretsen S, Bohlin J (2019) Statistical predictions with glmnet. Clin Epigenetics 11(1):123

Article  PubMed  PubMed Central  Google Scholar 

Gerber B, Freund M, Reimer T (2010) Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life. Deutsches Arzteblatt Int 107(6):85–91

Google Scholar 

Guo JN, Chen D, Deng SH, Huang JR, Song JX, Li XY et al (2022) Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer. Cancer Immunol Immunother : CII 71(6):1313–1330

Article  CAS  PubMed  Google Scholar 

Hänzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma 14:7

Article  Google Scholar 

Hassannia B, Vandenabeele P, Vanden BT (2019) Targeting ferroptosis to iron out cancer. Cancer Cell 35(6):830–849

Article  CAS  PubMed  Google Scholar 

Hu J, Huang H, Xi Z, Ma S, Ming J, Dong F et al (2022) LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis. Cell Death Dis 13(9):800

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jézéquel P, Kerdraon O, Hondermarck H, Guérin-Charbonnel C, Lasla H, Gouraud W et al (2019) Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications. Breast Cancer Res : BCR 21(1):65

Article  PubMed  PubMed Central  Google Scholar 

Kim YJ, Zhao Y, Myung JK, Yi JM, Kim MJ, Lee SJ (2021) Suppression of breast cancer progression by FBXL16 via oxygen-independent regulation of HIF1α stability. Cell Rep 37(8):109996

Article  CAS  PubMed  Google Scholar 

Klempner SJ, Fabrizio D, Bane S, Reinhart M, Peoples T, Ali SM et al (2020) Tumor mutational burden as a predictive biomarker for response to immune checkpoint inhibitors: a review of current evidence. Oncologist 25(1):e147–e159

Article  PubMed  Google Scholar 

Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD (2012) The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics (Oxford, England) 28(6):882–883

CAS  PubMed  Google Scholar 

Li Y, Liang Y, Sang Y, Song X, Zhang H, Liu Y et al (2018) MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1. Cell Death Dis 9(1):14

Article  PubMed  PubMed Central  Google Scholar 

Li DD, Deng L, Hu SY, Zhang FL, Li DQ (2020) SH3BGRL2 exerts a dual function in breast cancer growth and metastasis and is regulated by TGF-β1. Am J Cancer Res 10(4):1238–1254

PubMed  PubMed Central  Google Scholar 

Li J, Wang S, Wang N, Zheng Y, Yang B, Wang X et al (2021) Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration. Cell Commun Signal 19(1):89

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang W, Gao R, Yang M, Wang X, Cheng K, Shi X et al (2020) MARCKSL1 promotes the proliferation, migration and invasion of lung adenocarcinoma cells. Oncol Lett 19(3):2272–2280

CAS  PubMed  PubMed Central  Google Scholar 

Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P (2015) The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst 1(6):417–425

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin Y, Xu J, Lan H (2019) Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol 12:76

Article  PubMed  PubMed Central  Google Scholar 

Liu Z, Mi M, Li X, Zheng X, Wu G, Zhang L (2020) A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer. J Cell Mol Med 24(21):12444–12456

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu TT, Li R, Huo C, Li JP, Yao J, Ji XL et al (2021a) Identification of CDK2-related immune forecast model and ceRNA in lung adenocarcinoma, a pan-cancer analysis. Front Cell Dev Biol 9:682002

Article  PubMed  PubMed Central  Google Scholar 

Liu C, Qiang J, Deng Q, Xia J, Deng L, Zhou L et al (2021b) ALDH1A1 activity in tumor-initiating cells remodels myeloid-derived suppressor cells to promote breast cancer progression. Can Res 81(23):5919–5934

Article  CAS  Google Scholar 

Lv W, Wang Y, Zhao C, Tan Y, Xiong M, Yi Y et al (2021) Identification and validation of m6A-related lncRNA signature as potential predictive biomarkers in breast cancer. Front Oncol 11:745719

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyons TG (2019) Targeted therapies for triple-negative breast cancer. Curr Treat Options Oncol 20(11):82

Article  PubMed  Google Scholar 

Mao X, Zhou X, Liu J, Mao Y, Zhou H (2022) Retracted: Up-regulated Linc00472 suppresses development of lung cancer cell via inhibition of MiR-196b-5p. Biosci Biotechnol Biochem 86(8):e1–e13

PubMed  Google Scholar 

Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747–1756

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C et al (2015) Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer 121(2):269–275

Article  CAS  PubMed  Google Scholar 

Mittal S, Brown NJ, Holen I (2018) The breast tumor microenvironment: role in cancer development, progression and response to therapy. Expert Rev Mol Diagn 18(3):227–243

Article  CAS  PubMed  Google Scholar 

Moy I, Todorović V, Dubash AD, Coon JS, Parker JB, Buranapramest M et al (2015) Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells. Oncogene 34(3):323–333

Article  CAS  PubMed  Google Scholar 

Neiger HE, Siegler EL, Shi Y (2021) Breast cancer predisposition genes and synthetic lethality. Int J Mol Sci 22(11):5614

Ni H, Ji D, Huang Z, Li J (2020) SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway. Arch Biochem Biophys 695:108628

Article  CAS  PubMed  Google Scholar 

Ogłuszka M, Orzechowska M, Jędroszka D, Witas P, Bednarek AK (2019) Evaluate cutpoints: adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator. Comput Methods Programs Biomed 177:133–139

Article  PubMed  Google Scholar 

Onesti CE, Josse C, Boulet D, Thiry J, Beaumecker B, Bours V et al (2020) Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse. Oncoimmunology 9(1):1761176

Article  PubMed  PubMed Central  Google Scholar 

Ownby HE, Roi LD, Isenberg RR, Brennan MJ (1983) Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer 52(1):126–130

Article  CAS  PubMed